Recent Investment Analysts’ Ratings Changes for Schrodinger (SDGR)

Several analysts have recently updated their ratings and price targets for Schrodinger (NASDAQ: SDGR):

• 10/16/2026 – Schrodinger had its price target raised by KeyCorp from $20.00 to $32.00. They now have an “overweight” rating on the stock.
• 10/13/2026 – Schrodinger had its price target raised by TD Cowen from $20.00 to $31.00. They now have a “buy” rating on the stock.
• 10/12/2026 – Schrodinger had its price target raised by BMO Capital Markets from $24.00 to $30.00. They now have an “outperform” rating on the stock.
• 10/5/2026 – Schrodinger was upgraded by Zacks Research from “hold” to “strong-buy”.
• 8/27/2026 – Schrodinger was upgraded by Weiss Ratings from “sell (e+)” to “sell (d-)”.

Insider Buying and Selling

In other Schrodinger news, insider Karen Akinsanya sold 31,599 shares of Schrodinger stock in a transaction on Thursday, September 17th. The shares were sold at an average price of $29.37, for a total transaction of $928,062.63. Following the sale, the insider owned 69,956 shares in the company, valued at $2,054,607.72. The trade was a 31.12% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.10% of the stock is currently owned by company insiders.

Schrödinger, Inc is a technology company that develops computational software for pharmaceutical and materials research. Its platform uses physics-based modeling, machine learning and other computational methods to help scientists design and optimize molecules, evaluate potential drug candidates and investigate material properties.

The company’s software offerings include molecular modeling, simulation, predictive modeling and collaborative research tools, such as Maestro, Desmond, Jaguar, FEP+ and LiveDesign.